Canada Inspection 82014 - Intas Pharmaceuticals Limited - January 10, 2023

Canada Health Inspection 82014 for Intas Pharmaceuticals Limited on January 10, 2023. Rating: C. Access full inspection details and violations.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

Canada Health Inspection 82014 for Intas Pharmaceuticals Limited on January 10, 2023. Rating: C. Access full inspection details and violations.

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Intas Pharmaceuticals Limited

Inspection Date

January 10, 2023

Product Type

drugs

ID: a6325e9d-4773-4eb5-b038-2968d395d918

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox